Category: approved
-
Urban renewal plan approved in heart of Tel Aviv
•
Hhashmal neighborhood plan includes the old central bus station 30 floors. The Local Planning and Building Committee in Tel Aviv has approved this week a plan for the Hashemite Staqa at the corner of the Minatsem Biton road and Hahash North Street opposite the old central bus station. The plan…
-
Litecoin ETF Approved – What Crypto to Buy in a January?
•
Many fund managers recently submitted requests to Altcoin ETFS to the Securities and Exchange Committee (SEC), including $ DOGE, $ Trump and $ Meania ATFS. However, the only app for green light is Litecoin ETF from Canary Capital ($ LTC ETF). It is not surprising, the organizer rejects all other…
-
Ra’anana station moved as final section of Metro approved
•
The Israel Planning Authority announced today that the National Infrastructure Committee unanimously approved the final section of the M1 Line North of the Metro Mass Transit Project in the greater Tel Aviv area. This means that all three lines of the entire metro network have now been approved. The section…
-
750 apartments approved for Tel Aviv’s Ramat Hahayal
•
The Tel Aviv Local Planning and Building Committee rejected objections to the Dan Properties project planned at the entrance to Ramat HaHiyal in Tel Aviv. The Tel Aviv Local Planning and Building Committee rejected objections to the Dan Properties project planned at the entrance to Ramat Hahiyal in Tel Aviv,…
-
Medical School approved for Reichman University
•
80 medical students will be enrolled in the first four-year program, which will begin in February 2025. The annual fee is NIS 90,000. The Council for Higher Education in Israel granted approval to Reichman University Herzliya to establish a medical school. Last year, Reichmann University’s application was rejected on the…
-
Medical School approved for Reichman University
•
80 medical students will be enrolled in the first four-year program, which will begin in February 2025. The annual fee is NIS 90,000. The Council for Higher Education in Israel granted approval to Reichman University Herzliya to establish a medical school. Last year, Reichmann University’s application was rejected on the…
-
Despite objections 42-floor “Burj Jerusalem” tower approved
•
More than 200 objections did not stop the Jerusalem District Planning and Building Committee from approving a plan to build a 42-story tower near Mount Herzl in the capital, a source close to the matter told Globes. The controversial plan at the Epstein complex overlooks the Yad Vashem Holocaust memorial…
-
Housing purchase tax cut approved for new immigrants
•
The Knesset Finance Committee today approved an amendment to the real estate tax system regarding benefits for new immigrants who purchase real estate in Israel. The Knesset Finance Committee today approved an amendment to the real estate tax regulations regarding the benefits that new immigrants receive when purchasing real estate…
-
All Ethereum ETFs Approved, To Debut On 23 July 2024
•
The cryptocurrency markets have been eagerly awaiting the launch of Ethereum ETFs, and the wait is finally over. The U.S. Securities and Exchange Commission (SEC) has issued a consent A group of Ethereum-based exchange-traded funds (ETFs), paving the way for the ETFs to begin trading on July 23, 2024, the…
-
All Ethereum ETFs Approved, To Debut On 23 July 2024
•
The cryptocurrency markets have been eagerly awaiting the launch of Ethereum ETFs, and the wait is finally over. The U.S. Securities and Exchange Commission (SEC) has issued a consent A group of Ethereum-based exchange-traded funds (ETFs), paving the way for the ETFs to begin trading on July 23, 2024, the…
-
H.C. Wainwright optimistic on Biophytis stock as Phase 2 trial approved By Investing.com
•
HC Wainwright on Friday affirmed its buy rating and $15.00 price target on Biophytis SA (NASDAQ:BPTS) stock, following the company’s announcement that it has received FDA approval to begin a Phase 2 clinical study. The study, which will focus on BIO101 in patients with obesity, is scheduled to begin in…
-
“LEQEMBI” Lecanemab) Approved for the Treatment of Alzheimer’s Disease in Israel By Investing.com
•
TOKYO and CAMBRIDGE, Mass., July 12, 2024 – (JCN NewsWire) – Eisai Co., Ltd. (OTC:) and Biogen Co., Ltd. (NASDAQ:) today announced the approval of the beta-amyloid (Aβ)-degrading monoclonal antibody “LEQEMBI” (generic name: lecanemab) in Israel as a treatment for Alzheimer’s disease (AD). Treatment with LEQEMBI should be initiated in…
-
Solana Vs. XRP ETF: Expert Predicts Which One Will Be Approved First
•
Recent developments with Ethereum ETFs It led to discussions about which crypto token could have its own ETF next. Solana (SOL) and XRP ETFs has taken center stage, with experts debating which one will come first. Experts say the Solana ETF is next Brian Kelly, founder of digital asset investment…
-
Solana Vs. XRP ETF: Expert Predicts Which One Will Be Approved First
•
Recent developments with Ethereum ETFs It led to discussions about which crypto token could have its own ETF next. Solana (SOL) and XRP ETFs has taken center stage, with experts debating which one will come first. Experts say the Solana ETF is next Brian Kelly, founder of digital asset investment…